Current advances in ischemic stroke management
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.066Keywords
ischemic stroke, mechanical thrombectomy, neurology, cerebral strokeAbstract
Stroke is one of the leading causes of morbidity and mortality worldwide with 24.1 million new stroke cases in 2017 and 700,000 more stroke-related deaths, as compared to 2016. Although some patients recover after a stroke, the significant majority continue to have numerous health problems resulting in substantial decrease of life quality. This article reviews the evaluation and the current advances in the management of acute ischemic stroke, starting in the prehospital setting followed by stroke hospital management.
Conclusions: Appropriate treatment of ischemic stroke is essential in the reduction of mortality and morbidity. Therapeutic methods have greatly expanded beyond the utility of intravenous thrombolysis, with more advanced and complex techniques. Mechanical thrombectomy has revolutionised the management through the clot retrieval techniques improving patient outcomes. Appropriate application of the available treatment methods is crucial to optimising outcomes of patients with stroke, starting from pre-hospital accurate assessment. High-quality care of patients with ischemic stroke requires efficient cooperation of multidisciplinary medical staff.
References
Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141:e139–e596
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145(8):e153-e639
Kumar S., Selim M.H., Caplan L.R. Medical complications after stroke. Lancet Neurol. 2010;9:105–118
GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439-458
Strilciuc S, Grad DA, Radu C, et al. The economic burden of stroke: a systematic review of cost of illness studies. J Med Life. 2021;14(5):606-619
Knight-Greenfield A, Nario JJQ, Gupta A. Causes of Acute Stroke: A Patterned Approach. Radiol Clin North Am. 2019;57(6):1093-1108
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021;16(2):137-149
Vidale S, Agostoni E. Prehospital stroke scales and large vessel occlusion: A systematic review. Acta Neurol Scand. 2018;138(1):24-31
Brott T., Adams H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 1989;20:864–870
Hasan TF, Hasan H, Kelley RE. Overview of Acute Ischemic Stroke Evaluation and Management. Biomedicines. 2021;9(10):1486
Barber A.P., Demchuk A.M., Zhang J., Buchan A.M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000;355:1670–1674
Murray NM, Unberath M, Hager GD, Hui FK. Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review. J Neurointerv Surg. 2020;12(2):156-164
Rabinstein AA. Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):62-81
Alonso de Leciñana M, Egido JA, Casado I, et al. Guidelines for the treatment of acute ischaemic stroke, Neurología. 2014:102—122
Teekaput C, Thiankhaw K, Tanprawate S, Teekaput K, Chai-Adisaksopha C. Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage. PLoS One. 2022;17(8):e0272257
Wang X, Ouyang M, Yang J, Song L, Yang M, Anderson CS. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2021;10(10):CD000024
Burgos AM, Saver JL. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke meta-analysis of 5 randomized trials. Stroke 2019;50:2156–62
Albers G.W., Marks M.P., Kemp S. et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N. Engl. J. Med. 2018;378:708–718
Nogueira R.G., Jadhav A.P., Haussen D.C. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2018;378:11–21
Goyal, M, Menon, BK, van Zwam, WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–1731
Yang P, Zhang Y, Liu J. LAST2 CH2ANCE: A Summary of Selection Criteria for Thrombectomy in Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2017;38(9):E58-E59
Gong C, Huang J, Kong W, et al. Five-Year Outcomes After Endovascular Treatment for Large Vessel Occlusion Stroke. Front Neurosci. 2022;16:920731
Baker TS, Robeny J, Cruz D, et al. Stimulating the Facial Nerve to Treat Ischemic Stroke: A Systematic Review. Front Neurol. 2021;12:753182
Kim JA, Kim YY, Lee SH, Jung C, Kim MH, Kim DY. Neuroprotective Effect of Macrophage Migration Inhibitory Factor (MIF) in a Mouse Model of Ischemic Stroke. Int J Mol Sci. 2022;23(13):6975
Chang MC, Park CR, Rhie SH, Shim WH, Kim DY. Early treadmill exercise increases macrophage migration inhibitory factor expression after cerebral ischemia/reperfusion. Neural Regen Res. 2019;14(7):1230-1236
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Justyna Żyga
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 341
Number of citations: 0